In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...